Insider · CIK 0001741389
Mahoney Stephen F.
Reports to the SEC for 3 companies · WALTHAM, MA
Transactions
25
Companies
3
Filings
15
CIK
0001741389
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-03 | VRDNViridian Therapeutics, Inc.\DEF Tax Payment | −$224K |
| 2026-03-03 | VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion | — |
| 2026-03-03 | VRDNViridian Therapeutics, Inc.\DEF Tax Payment | −$224K |
| 2026-03-03 | VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-03-02 | VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award | — |
| 2026-03-02 | VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsA Award | — |
| 2025-03-03 | VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award | — |
| 2025-03-03 | VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsA Award | — |
| 2024-09-27 | VRDNViridian Therapeutics, Inc.\DEP Purchase | +$499K |
| 2023-10-30 | VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award | — |
| 2022-11-30 | DNTHDianthus Therapeutics, Inc. /DE/A Award | +$2,820 |
| 2022-08-01 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-05-17 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-02-15 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2021-09-16 | DNTHDianthus Therapeutics, Inc. /DE/S Sale | −$38.6K |
| 2021-09-14 | DNTHDianthus Therapeutics, Inc. /DE/A Award | — |
| 2020-11-02 | DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2019-09-17 | KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award | — |
| 2019-03-04 | KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award | — |
| 2018-09-20 | KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award | — |
| 2018-05-29 | KNSAKiniksa Pharmaceuticals International, plcC Conversion | — |
| 2018-05-29 | KNSAKiniksa Pharmaceuticals International, plc · Series A Preferred SharesC Conversion | — |
| 2018-05-29 | KNSAKiniksa Pharmaceuticals International, plc · Series C Preferred SharesC Conversion | — |
| 2018-05-29 | KNSAKiniksa Pharmaceuticals International, plc · Class B Common SharesC Conversion | — |
| 2018-02-09 | KNSAKiniksa Pharmaceuticals International, plc · Series C Preferred SharesP Purchase | +$100K |
Recent filings
- 4/AMahoney Stephen F.0001193125-26-099007SEC(opens sec.gov)
- 4Mahoney Stephen F.0001193125-26-092036SEC(opens sec.gov)
- 4Mahoney Stephen F.0000950170-25-032891SEC(opens sec.gov)
- 4Mahoney Stephen F.0000950170-24-110484SEC(opens sec.gov)
- 4Mahoney Stephen F.0000950170-23-057519SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-22-037433SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-22-027266SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-22-018804SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-22-006814SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-21-036601SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-21-036337SEC(opens sec.gov)
- 4Mahoney Stephen F.0000899243-20-030392SEC(opens sec.gov)
- 4Mahoney Stephen F.0001179110-19-010490SEC(opens sec.gov)
- 4Mahoney Stephen F.0001104659-19-013176SEC(opens sec.gov)
- 4Mahoney Stephen F.0001104659-18-058109SEC(opens sec.gov)
Companies
Address
C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 103A
WALTHAM, MA, 02453